AU7370594A - Methods of treating apoptosis and associated conditions - Google Patents

Methods of treating apoptosis and associated conditions

Info

Publication number
AU7370594A
AU7370594A AU73705/94A AU7370594A AU7370594A AU 7370594 A AU7370594 A AU 7370594A AU 73705/94 A AU73705/94 A AU 73705/94A AU 7370594 A AU7370594 A AU 7370594A AU 7370594 A AU7370594 A AU 7370594A
Authority
AU
Australia
Prior art keywords
methods
associated conditions
treating apoptosis
apoptosis
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73705/94A
Inventor
L. David Tomei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LXR Biotechnology Inc
Original Assignee
LXR Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LXR Biotechnology Inc filed Critical LXR Biotechnology Inc
Publication of AU7370594A publication Critical patent/AU7370594A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU73705/94A 1993-07-23 1994-07-22 Methods of treating apoptosis and associated conditions Abandoned AU7370594A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9678893A 1993-07-23 1993-07-23
US096788 1993-07-23
PCT/US1994/008268 WO1995003054A1 (en) 1993-07-23 1994-07-22 Methods of treating apoptosis and associated conditions

Publications (1)

Publication Number Publication Date
AU7370594A true AU7370594A (en) 1995-02-20

Family

ID=22259083

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73705/94A Abandoned AU7370594A (en) 1993-07-23 1994-07-22 Methods of treating apoptosis and associated conditions

Country Status (7)

Country Link
EP (1) EP0711168A4 (en)
JP (1) JPH09503749A (en)
KR (1) KR960703597A (en)
AU (1) AU7370594A (en)
BR (1) BR9407145A (en)
CA (1) CA2167805A1 (en)
WO (1) WO1995003054A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3866800B2 (en) * 1996-08-29 2007-01-10 東菱薬品工業株式会社 Prophylactic and / or therapeutic agent for apoptosis-related diseases
KR20020035131A (en) * 1999-09-10 2002-05-09 시아투스 엑스크비레레 파마포르슝스 게엠베하 Use dexrazoxane for treating psoriasis
YU17002A (en) 1999-09-10 2004-11-25 Cyathus Exquirere Pharmaforschungs Gmbh. Dextrazohane use in psoriasis healing
US6552025B1 (en) 1999-11-24 2003-04-22 Emory University Diimino-piperazine derivatives for use as modulators of cell regulation
AU5150200A (en) * 1999-11-24 2001-06-04 Emory University Diimino-piperazine derivatives for use as modulators of cell regulation
CN100553636C (en) 2000-08-04 2009-10-28 Dmi生物科学公司 Diketo-piperazine and the using method that comprises their compositions
CN103142599A (en) * 2003-05-15 2013-06-12 Dmi生物科学公司 Treatment of T-cell mediated diseases
CA2778126A1 (en) * 2003-06-24 2005-01-13 University Of Connecticut Methods of inhibiting vascular permeability and apoptosis
GB0314733D0 (en) * 2003-06-24 2003-07-30 Glaxo Group Ltd Medicaments
WO2008021250A2 (en) * 2006-08-10 2008-02-21 Fred Hutchinson Cancer Research Center Compositions and methods for modulating apoptosis in cells over-expressing bcl-2 family member proteins
EP2300011A4 (en) 2008-05-27 2012-06-20 Dmi Life Sciences Inc Therapeutic methods and compounds
WO2012033792A2 (en) 2010-09-07 2012-03-15 Dmi Acquisition Corp. Treatment of diseases
EP2766029B1 (en) 2011-10-10 2020-03-25 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
US9925300B2 (en) 2011-10-10 2018-03-27 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
SG11201400283RA (en) 2011-10-28 2014-03-28 Ampio Pharmaceuticals Inc Treatment of rhinitis
SG10201707619RA (en) 2013-03-15 2017-10-30 Ampio Pharmaceuticals Inc Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
RU2020136589A (en) 2014-08-18 2020-12-24 Ампио Фармасьютикалз, Инк. TREATMENT OF DEGENERATIVE JOINT DISEASES
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8916072D0 (en) * 1989-07-13 1989-08-31 Creighton Andrew M Pharmaceutical compositions
GB9024861D0 (en) * 1990-11-15 1991-01-02 Hellmann Kurt Bis-dioxopiperazines for treating liver tumors

Also Published As

Publication number Publication date
CA2167805A1 (en) 1995-02-02
EP0711168A4 (en) 1998-04-01
JPH09503749A (en) 1997-04-15
WO1995003054A1 (en) 1995-02-02
BR9407145A (en) 1996-09-17
EP0711168A1 (en) 1996-05-15
KR960703597A (en) 1996-08-31

Similar Documents

Publication Publication Date Title
ZA965088B (en) Methods of preventing or treating allergles
AU7419096A (en) Treatment of vegetables
AU6797094A (en) Cosmetic treatment of substrates
AU7370594A (en) Methods of treating apoptosis and associated conditions
AU2103295A (en) Methods for the treatment of thrombosis
AU3519893A (en) Antitumor compositions and methods of treatment
AU8154294A (en) Methods of inhibiting atrophy of the skin and vagina
AU3937593A (en) Trans-sialidase and methods of use and making thereof
AU1115095A (en) Treatment of cellulose
AU6946594A (en) Methods for the treatment and prevention of diarrhea
AU5644494A (en) Surface treated applicators and related methods
AU1394795A (en) Method and device for the continuous cooking of pulp
AU6821994A (en) Electrode-carrying catheter and method of making same
AU7065694A (en) Catheter and method of use thereof
AU3730093A (en) Methods of treating diabetes
AU6369094A (en) Ige isoforms and methods of use
AU675283B2 (en) Method of treating night soil and apparatus therefor
AU5528996A (en) Methods of treating or preventing pain or nociception
AU2843397A (en) Agent for prophylaxis and treatment of disturbance of visual function
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AU3973793A (en) Method of treating cancer
AU1429792A (en) Method for the treatment of the sewages and respective plant
EP0583687A3 (en) Method for the preparation of substituted methoxyphenols and microorganisms therefore
AU7113996A (en) Methods of treating beta-amyloid-associated conditions
AU1097892A (en) Process and installation for the treatment of steel-mill slag